Want to see IEX full AI Analyst Report?
IEX Stock Chart & Stats
$205.92
-$0.65(-0.31%)
At close: 4:00 PM EST
$205.92
-$0.65(-0.31%)
Day’s Range― - ―
52-Week Range$157.25 - $230.18
Previous CloseN/A
Volume173.43K
Average Volume (3M)715.00K
Market Cap
$16.80B
Enterprise Value$17.87B
Total Cash (Recent Filing)$586.20M
Total Debt (Recent Filing)$1.90B
Price to Earnings (P/E)33.5
Beta0.96
Next Earnings
Jul 29, 2026EPS Estimate
2.11Next Dividend Ex-DateN/A
Dividend Yield1.56%
Share Statistics
EPS (TTM)6.77
Shares Outstanding74,015,050
10 Day Avg. Volume787,309
30 Day Avg. Volume714,996
Financial Highlights & Ratios
PEG Ratio-7.12
Price to Book (P/B)3.33
Price to Sales (P/S)3.88
P/FCF Ratio21.72
Enterprise Value/Market Cap1.06
Enterprise Value/Revenue5.06
Enterprise Value/Gross Profit11.40
Enterprise Value/Ebitda19.02
Forecast
1Y Price Target
$246.10Price Target Upside19.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)8.47
Revenue Forecast (FY)$3.63B
Bulls Say, Bears Say
Bulls Say
HST Outperformance & BacklogSustained double-digit orders and revenue growth in the Health & Science Technologies platform, plus a 100bp EBITDA margin lift and an expanding backlog, signal durable end-market demand (data centers, semiconductors, pharma). This provides multi-quarter visibility and supports above-company organic growth over time.
Strong Liquidity & Capital AllocationLarge liquidity reserves, moderate gross leverage (~2x) and disciplined buybacks plus steady dividends create financial optionality for bolt-on M&A and cyclical buffering. This capital flexibility supports long-term strategic execution and shareholder returns without materially stressing the balance sheet.
Consolidated Margin ExpansionYear-over-year EBITDA margin improvement indicates effective cost discipline and pricing power across the diversified portfolio. If sustained, these structural productivity gains and pricing actions can improve earnings resiliency through cycles and fund reinvestment or M&A without eroding returns.
Bears Say
Volatile Free Cash FlowDespite strong cash conversion in typical periods, the large TTM FCF drop signals material volatility tied to working capital or investment timing. This undermines predictability for capex, acquisitions and buybacks, raising the risk that funding patterns or returns fluctuate materially across reporting periods.
Life Sciences End-market PressureWeakness in life-science demand, especially from China and constrained public funding, can permanently pressure higher-margin product mix in HST and adjacent segments. Prolonged softness would limit margin expansion potential and slow the pace at which acquired businesses can be accretive to overall profitability.
Incremental Margin & Mix HeadwindsAcquisition-driven mix shifts and lower-margin add-ons reduce incremental flow-through, meaning revenue gains translate less efficiently into EBITDA. This structural drag requires 8020 portfolio actions to restore higher incremental margins and could delay margin targets while integration and portfolio optimization proceed.
IDEX News
IEX FAQ
What was Idex Corporation’s price range in the past 12 months?
Idex Corporation lowest stock price was $157.25 and its highest was $230.18 in the past 12 months.
What is Idex Corporation’s market cap?
Idex Corporation’s market cap is $16.80B.
When is Idex Corporation’s upcoming earnings report date?
Idex Corporation’s upcoming earnings report date is Jul 29, 2026 which is in 28 days.
How were Idex Corporation’s earnings last quarter?
Idex Corporation released its earnings results on Apr 29, 2026. The company reported $2 earnings per share for the quarter, beating the consensus estimate of $1.769 by $0.231.
Is Idex Corporation overvalued?
According to Wall Street analysts Idex Corporation’s price is currently Undervalued.
Does Idex Corporation pay dividends?
Idex Corporation pays a Quarterly dividend of $0.73 which represents an annual dividend yield of 1.56%. See more information on Idex Corporation dividends here
What is Idex Corporation’s EPS estimate?
Idex Corporation’s EPS estimate is 2.11.
How many shares outstanding does Idex Corporation have?
Idex Corporation has 74,015,050 shares outstanding.
What happened to Idex Corporation’s price movement after its last earnings report?
Idex Corporation reported an EPS of $2 in its last earnings report, beating expectations of $1.769. Following the earnings report the stock price went up 5.834%.
Which hedge fund is a major shareholder of Idex Corporation?
Currently, no hedge funds are holding shares in IEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IDEX Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$246.10 (19.51% Upside)
$246.10 (19.51% Upside)
Blogger Sentiment
Neutral
IEX Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 6.9%
Last 30 Days ▼ 6.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.13%
12-Months-Change
Fundamentals
Return on Equity
12.61%
Trailing 12-Months
Asset Growth
1.82%
Trailing 12-Months
Company Description
Idex Corporation
IDEX Corporation is an international enterprise specializing in engineered solutions across diverse sectors. The company operates through three primary business units: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT division is responsible for the design, production, and distribution of a range of fluid-handling equipment, including positive displacement pumps, flow meters, and injectors, alongside offering flow monitoring and related services. Its applications span the food, chemical, general industrial, water management, agricultural, and energy industries. Under the HST umbrella, IDEX develops and supplies precision components and systems for health and scientific applications. This includes advanced fluidic devices, various types of pumps (rotary lobe, centrifugal, positive displacement), roll compaction and drying technologies, pneumatic components, and sealing solutions, as well as biocompatible medical devices, optical components, and precision photonic solutions. Key markets for this segment encompass food and beverage, pharmaceutical, cosmetics, marine, chemical, wastewater treatment, life sciences, research, and defense. Finally, the FSDP segment delivers critical equipment for emergency services, such as firefighting pumps, valves, rescue tools, and lifting bags. It also provides engineered stainless steel banding and clamping devices for industrial and commercial use, alongside specialized precision equipment for dispensing, metering, and mixing colorants and paints for retail and commercial clients. IDEX Corporation was founded in 1987 and maintains its headquarters in Northbrook, Illinois.
IEX Company Deck
IEX Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call skewed positive: management reported better-than-expected Q1 results, raised full-year organic growth and EPS guidance, highlighted strong HST order and revenue momentum with meaningful backlog and margin expansion, maintained aggressive share repurchases and an active bolt-on M&A pipeline, and ended the quarter with strong liquidity. Offsetting items include mixed short-cycle industrial performance, pressure in life sciences and some gross margin/mix headwinds; free cash flow was modestly lower in the seasonally weak quarter. On balance, the positive operational progress, upgraded guidance and financial optionality outweigh the contained challenges.View all IEX earnings summariesIEX Net sales Breakdown
35.36% Fluid & Metering Technologies
43.11% Health & Science Technologies
21.53% Fire & Safety/Diversified Products
IEX Stock 12 Month Forecast
Average Price Target
$246.10
▲(19.51% Upside)
Technical Analysis
Ownership Overview
0.21% Insiders
28.38% Mutual Funds
24.21% Other Institutional Investors
15.80% Public Companies and
Individual Investors